← All sarcoma trials
Recruiting nowN/AAges 18 Years to 99 Years

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Sponsor: Istituto Oncologico Veneto IRCCS · NCT06753136 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Primary Visceral Tumors of Any HistotypeVisceral LesionsLiver CancerLiver Metastasis Colon CancerMelanomaPrimary Pancreatic TumorRetroperitoneal SarcomaAbdominal and/or Peritoneal LocalizationsMerkel Cell CarcinomaSquamous Cell CarcinomaSecondary Visceral Localizations of Any HistotypeNon-melanoma Skin Cancer

What it tests

  • percutaneous, laparoscopic or laparotomy lesion electrochemotherapydevice

Where it's running1 site

1 international site
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Male/Female ≥ 18 years
* Ability to understand the proposed treatment and express an informed acceptance by signing the informed consent
* Diagnosis of primary and/or secondary visceral localizations of any histotype
* Patients who are not eligible for standard curative procedures

Exclusion Criteria:

* Absolute contraindications to invasive procedures
* Concomitant presence of brain, lung, bone metastases
* Uncorrectable coagulation changes
* Bleomycin allergy
* Absolute contraindications to taking Bleomycin
* Poor respiratory function or pulmonary fibrosis
* Acute lung infections
* Is pregnant or breastfeeding or expecting to conceive or father children within the projected duration of the study

Updated 2026-04-13 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.